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Colonic polypectomy is one of the most powerful toolsused in clinical medicine. There is really no other
organ system where cancer mortality can almost be com-
pletely prevented by an examination that does not disturb
the anatomy or function of the organ. In nine studies
involving more than 3000 patients with colonic adenomas
who underwent clearing colonoscopy and then follow-up
surveillance (including the National Polyp Study and the
Funen Adenoma Follow-up Study), there have been 19
incident colorectal cancers, but only one death from colorec-
tal cancer (1).
POSTPOLYPECTOMY SURVEILLANCE
The principal study that guides postpolypectomy surveil-
lance is the National Polyp Study (2).  The National Polyp
Study was a randomized, controlled trial in which patients
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15(1):57-59. Patients undergoing clearing colonoscopy with
resection of adenomas should generally have their next exami-
nation at three years.  Exceptions include large sessile adenomas
removed piecemeal (re-examine at two to six months until no
evidence of recurrent polyp, then at one year), average risk
patients with a single tubular adenoma (next examination at
five years) and patients with ‘numerous’ adenomas (next exami-
nation at one or two years). 
Patients with surgically resected colorectal cancer should have a
clearing colonoscopy preoperatively or within two to three
months of surgery in obstructed patients, even if the preopera-
tive barium enema is negative for proximal lesions. After the
clearing colonoscopy, subsequent examinations can be per-
formed based on the associated adenoma findings.
Key Words: Adenomas; Colonoscopy; Colorectal cancer;
Colorectal polyps
Coloscopie de contrôle à la suite de la 
résection de tumeurs cancéreuses ou de
polypes colorectaux
Les patients qui subissent une coloscopie exploratoire avec résection
d’adénomes devraient généralement être soumis à un examen de con-
trôle au bout de trois ans. Il y a toutefois certaines exceptions : les résec-
tions parcellaires d’adénomes sessiles volumineux (examen de contrôle
aux deux à six mois jusqu’à l’absence objective de réapparition de
polypes, puis un an plus tard), les résections d'un adénome tubuleux
unique chez les patients à risque moyen (examen de contrôle dans cinq
ans) et les résection d’adénomes multiples (examen de contrôle dans un
an ou deux). Les patients opérés pour un cancer colorectal devraient
subir une coloscopie exploratoire en phase préopératoire ou de deux à
trois mois avant l’intervention chez les patients présentant une occlu-
sion, et ce, même si le lavement baryté en phase préopératoire s’avère
négatif pour les lésions proximales. Après la coloscopie exploratoire, les
examens de contrôle devraient être pratiqués en fonction des résultats
d'analyse des adénomes.
who had undergone clearing colonoscopy were randomly
assigned to receive colonoscopy at one year and three years,
compared with three years only. Patients with malignant
polyps or with sessile adenomas larger than 3 cm were
excluded from the study. The primary end point of the study
was the occurrence of advanced adenomas at follow-up. An
advanced adenoma was defined as one with severe (‘high
grade’) dysplasia or invasive cancer. The principal finding
of the study was that the incidence of advanced adenomas
was equivalent in the two study arms at 3%. Thus, it was
concluded that most patients could have their first follow-
up colonoscopy three years after clearing colonoscopy.
It should be noted that the National Polyp Study is very
much a miss rate study. Patients in the arm that received
two colonoscopies were more likely to have an adenoma
detected (42% compared with 32%) and had a total of
about 40% more adenomas than the group that had only
one colonoscopy. Thus, because the randomization was
effective, one can conclude that the miss rate for adenomas
in the National Polyp Study was approximately 40%. This
miss rate is, in fact, higher than the miss rate for adenomas
seen in two tandem colonoscopy studies in which patients
underwent colonoscopy twice in the same day (3,4). The
inescapable conclusion is that, while colonoscopy has a sub-
stantial miss rate for small polyps, including small adeno-
mas, this miss rate has almost no bearing on its effectiveness
in reducing mortality from colorectal cancer.
The new colorectal cancer screening benefit for American
Medicare beneficiaries includes patients with previous ade-
nomas among those in the ‘high risk’ group. The Medicare
benefit allows payment for colonoscopy at an interval of
every two years in patients with previous adenomas or can-
cer. In fact, essentially all society guidelines had already
been changed to recommend three-year intervals after
polypectomy or after clearing colonoscopy in cancer
patients by the time the Medicare benefit was written.
Certainly it is important that clinicians perform colon-
oscopy in most patients at three-year intervals rather then
the two-year intervals that are covered in the American
Medicare benefit.
There are situations in which deviation from the three-
year interval is clinically appropriate. The most important
situation is that of the patient with a large sessile polyp, par-
ticularly one that is removed in a piecemeal fashion. As
noted above, patients with sessile adenomas larger than
3 cm in size were excluded from the National Polyp Study.
In fact, large sessile adenomas are the most dangerous colon
polyps encountered in clinical practice. They are more like-
ly to contain invasive cancer, more likely to contain cancer
associated with lymph node metastases and more likely to
recur after apparent complete endoscopic resection than
any other type of colon polyp (5). After apparent complete
resection, such polyps should be followed-up at two- to six-
month intervals. If there is apparent residual tissue, it
should be removed, preferably by snare polypectomy or
obliterated by electrocoagulation after biopsy. The recur-
rence rate after removal of large sessile polyps is 16% to
28%. In addition, a significant number of recurrences can
develop one year after complete resection. Therefore, even
after apparent complete resection has been verified, it may
be best to perform the next colonoscopy in one year.
Another situation in which deviation from the three-
year interval is appropriate is a patient with ‘numerous’ ade-
nomas. In multiple studies, multiplicity of adenomas has
been a predictor of advanced adenomas at follow-up. In the
National Polyp Study, the most important predictor of an
advanced adenoma during follow-up was the presence of
three or more adenomas at the index clearing colonoscopy.
The guideline published by the Agency for Healthcare
Policy and Research (6) states that it is still appropriate to
perform a colonoscopy at one year in a patient with ‘numer-
ous’ adenomas. Obviously, this leaves the definition of
‘numerous’ up to the clinician’s judgment. In my own prac-
tice, fewer adenomas would be required to stimulate an exam-
ination at one or two years if one or more is larger than 1 cm.
Another potential exception to the three-year rule is the
patient with only a single tubular adenoma less than 1 cm
in size. The chance that such a patient will have an
advanced adenoma at follow-up colonoscopy at three years
appears to be less than 1% (2). It would seem reasonable in
such patients to expand the interval to five years, although
direct observational data from the National Polyp Study,
which thus far have only been abstracted (7), show that a
family history of colorectal cancer, particularly in a person
older than 60 years of age, was another predictor of
advanced ademonas at first follow-up. Therefore, it is not
my own practice to extend the follow-up interval to five
years in patients with single tubular adenomas who also
have a family history of colorectal neoplasia, but rather to
maintain the interval at three years in those patients.
POSTCANCER RESECTION
It should be noted that follow-up of colon cancer is direct-
ed toward identifying metachronous lesions. This is partic-
ularly true above the rectum, where the anastomotic
recurrence rate is only 2% to 3% (1), and most anastomot-
ic recurrences signal intra-abdominal recurrences that are
unresectable for cure. The anastomotic recurrence rate in
the rectum is around 10% and varies with surgical tech-
nique, but still there is no clear evidence that regular fol-
low-up by flexible sigmoidoscopy can improve the survival
rate. Additional study is needed to determine whether reg-
ular examination that includes endoscopic ultrasound can
increase the identification of surgically curable rectal recur-
rences. The most important examination for patients with
colon cancer is the colonoscopy that clears the colon of
synchronous disease. If this cannot be performed preopera-
tively because of obstruction, it should be performed two to
three months after surgery, even if a preoperative barium
enema revealed no synchronous disease proximal to the
tumour. Once the colon has been cleared, repeating colon-
oscopy at three- to five-year intervals is adequate (8), or
according to the associated adenoma findings. An excep-
tion is patients with hereditary nonpolyposis colorectal
Rex
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cancer, who should be treated with subtotal colectomy fol-
lowed by annual endoscopy of the rectum for the remainder
of their lives.
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